• Latest Posts
ADVERTISEMENT

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

Korro Bio and Frequency Therapeutics to merge

In Depth 10 Jul 2023

“Ready-to-use” enzymatically produced cell-free synthetic DNA in mRNA manufacturing

Flamingo Therapeutics receives €1.7M to advance RNA-targeting oncology portfolio

ADVERTISEMENT